Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
Abstract Generation of immunity against cancer through vaccination has long been an elusive goal for tumor immunologists. Putative candidates for vaccination targets include oncofetal antigens, viral antigens, neoantigens, and differentiation antigens. The first attempts at cancer vaccination used i...
Main Authors: | Robert J. Soiffer, Kameron A. Kooshesh, Vincent Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | ImmunoMedicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/imed.1025 |
Similar Items
-
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes
by: Markus D. Lacher, et al.
Published: (2018-05-01) -
Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model
by: Jiantai Timothy Qiu, et al.
Published: (2019-03-01) -
The immunogenicity and anti-tumor effects of a lung cancer DNA vaccine harboring a MUC-1 and GM-CSF fusion gene
by: Zhen Yang, et al. -
GM-CSF: A Promising Target in Inflammation and Autoimmunity
by: Lee KMC, et al.
Published: (2020-10-01) -
Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF
by: Hong-Wei Sun, et al.
Published: (2021-02-01)